Brenig Therapeutics, a portfolio company of Torrey Pines Investments, OrbiMed Advisors, and BioGeneration Ventures, announces new data on its LRRK2 inhibitor drug candidate, BT-0267. The results...

West expands administration systems portfolio with new smaller size needle-free admixture device for immediate use IV drug transfer designed to maximize the benefits of point-of-care nursing....

The Specialty Food Association is excited to announce the 2024 Winter Fancy Food Show (included) cohort. (included) is a mission-driven collective of BIPOC founders and executives, dedicated to...

J.B. Poindexter & Co., Inc. ("J.B. Poindexter") announced today that it has commenced a cash tender offer (the "Tender Offer") for any and all of its outstanding 7.125% Senior Notes due 2026...

BingX, a global leading cryptocurrency exchange, proudly announces its strategic sponsorship of NFT Taipei 2023, marking the second consecutive year of partnership with this prime event. NFT...